Details for New Drug Application (NDA): 019081
✉ Email this page to a colleague
The generic ingredient in ESTRADERM is estradiol. There are seventy-five drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the estradiol profile page.
Medical Subject Heading (MeSH) Categories for 019081
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SYSTEM;TRANSDERMAL | Strength | 0.05MG/24HR | ||||
Approval Date: | Sep 10, 1986 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SYSTEM;TRANSDERMAL | Strength | 0.1MG/24HR | ||||
Approval Date: | Sep 10, 1986 | TE: | RLD: | Yes |
Expired US Patents for NDA 019081
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | ESTRADERM | estradiol | SYSTEM;TRANSDERMAL | 019081-003 | Sep 10, 1986 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | ESTRADERM | estradiol | SYSTEM;TRANSDERMAL | 019081-002 | Sep 10, 1986 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | ESTRADERM | estradiol | SYSTEM;TRANSDERMAL | 019081-003 | Sep 10, 1986 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | ESTRADERM | estradiol | SYSTEM;TRANSDERMAL | 019081-002 | Sep 10, 1986 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | ESTRADERM | estradiol | SYSTEM;TRANSDERMAL | 019081-003 | Sep 10, 1986 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription